Paul Crisostomo, MD
Vascular Surgery · Maywood, ILNPI 1851589212
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $77,760 of the $94,829 with a category attached, or 82.0%. Silk Road Medical, Inc. accounts for 89.1% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2019 at $36,004 and has fallen 89.7% since, to $3,725 in 2025. Among vascular surgery clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 188 payments — averaging $504.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Silk Road Medical, Inc.$84K
- Penumbra, Inc.$4K
- Cardiovascular Systems Inc.$3K
- Inari Medical, Inc.$1K
- Smith+Nephew$578
- W. L. Gore & Associates, Inc.$449
- plus $2K from 25 others
What the payments were for
- Consulting fees$77,76082%
- Speaking & faculty fees$5,5106%
- Travel & lodging$6,8407%
- Food & beverage$4,7195%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Silk Road Medical, Inc. | 95 | $84,445 |
| Penumbra, Inc. | 6 | $3,791 |
| Cardiovascular Systems Inc. | 5 | $2,675 |
| Inari Medical, Inc. | 8 | $1,256 |
| Smith+Nephew | 20 | $578 |
| W. L. Gore & Associates, Inc. | 4 | $449 |
| Endologix LLC | 2 | $318 |
| Bolton Medical Inc | 5 | $256 |
| Cook Medical LLC | 5 | $212 |
| Bard Peripheral Vascular, Inc. | 3 | $130 |
| Medtronic | 3 | $128 |
| Organogenesis Inc. | 5 | $95 |
| Terumo Medical Corporation | 3 | $58 |
| Abbott | 2 | $44 |
| Stryker | 2 | $40 |
| Convatec Inc. | 1 | $37 |
| Bsn Medical Inc | 1 | $35 |
| BD | 1 | $35 |
| Argon Medical Devices, Inc. | 2 | $28 |
| Kerecis Limited | 2 | $23 |
| Imperative Care, Inc | 1 | $23 |
| Tactile Systems Technology Inc | 1 | $22 |
| Osiris Therapeutics Inc. | 1 | $22 |
| Medela LLC | 1 | $21 |
| Elutia, Inc. | 2 | $20 |
| Cordis US CORP. | 1 | $19 |
| Polynovo North America LLC | 2 | $18 |
| Johnson & Johnson | 1 | $18 |
| Lemaitre Vascular, Inc. | 1 | $17 |
| TEI Medical Inc. | 1 | $14 |
| Surmodics, Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENROUTE Transcarotid Neuroprotection System$83,374
- ENHANCE Transcarotid Peripheral Access Kit$78,184
- ENROUTE Transcarotid Stent System$57,527
- ENROUTE 0.014 Guidewire$57,527
- ENROUTE Transcarotid Stent$25,847
- ENROUTE .014 Guidewire$20,657
- Indigo System$3,200
- Peripheral Orbital Atherectomy System$2,310
- FLOWTRIEVER CATHETER, S$1,214
- CT THROMBECTOMY SYSTEM KIT$1,214
- Penumbra System$310
- AFX$266
- Diamondback Peripheral$182
- Diamondback Coronary$182
- Conformable TAG Thoracic Endoprosthesis$153
- Smart Coil$143
- Indigo$138
- Penumbra Ruby Coil$138
- GORE TAG Conformable Thoracic Endoprosthesis$137
- Cook Medical Aortic Intervention$121
How this compares
$94,829 in reported general payments places this provider in the 90th percentile of 170 vascular surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 124 | $99,399 |
| EliquisApixaban | 90 | $74,906 |
| Cilostazol | 70 | $1,457 |
| ClopidogrelClopidogrel Bisulfate | 78 | $1,153 |
| Atorvastatin Calcium | 73 | $550 |
| Pravastatin Sodium | 39 | $469 |
| Prasugrel Hcl | 11 | $449 |
| Gabapentin | 36 | $299 |
| Rosuvastatin Calcium | 15 | $71 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $59 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $18 | $99,399124 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 170 vascular surgery providers in Illinois.
Other vascular surgery in Maywood
- Carlos BecharaMaywood$199K
- Michael SoultMaywood$104K
- Pegge HalandrasMaywood$33K
- Ruojia LiMaywood$12K
- Ross MilnerChicago$1.3M
- Sapan DesaiArlington Heights$1.2M
- Nabeel RanaPeoria$934K
- Atif BaqaiPark Ridge$567K
- Trissa BabrowskiChicago$292K
- Tejas ShahDowners Grove$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.